A303810 logo

DK Life Science Co., Ltd. Stock Price

KOSDAQ:A303810 Community·₩74.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A303810 Share Price Performance

₩2,315.00
-2825.00 (-54.96%)
₩2,315.00
-2825.00 (-54.96%)
Price ₩2,315.00

A303810 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with adequate balance sheet.

1 Risk
2 Rewards

DK Life Science Co., Ltd. Key Details

₩128.4b

Revenue

₩94.6b

Cost of Revenue

₩33.8b

Gross Profit

₩25.1b

Other Expenses

₩8.7b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
272.46
26.33%
6.79%
27.3%
View Full Analysis

About A303810

Founded
2017
Employees
n/a
CEO
Jae Won Park
WebsiteView website
www.dkls.co.kr

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.

Recent A303810 News & Updates

Recent updates

No updates